“Nanotechnology-Driven Bioavailability Enhancement: A Critical Review of BCS Class II and IV Drugs”. Journal of Drug Discovery and Health Sciences, vol. 3, no. 03, Sept. 2026, pp. 63-71, https://doi.org/10.21590/d40skq78.